Cargando…

The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis

Tumor vessels provide essential paths for tumor cells to escape from the primary tumor and form metastatic foci in distant organs. The vessel targeting strategy has been widely used as an important clinical cancer chemotherapeutic strategy for patients with metastatic tumors. Our review introduces t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaobo, Li, Yong, Lu, Weijin, Chen, Minfeng, Ye, Wencai, Zhang, Dongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952935/
https://www.ncbi.nlm.nih.gov/pubmed/31835465
http://dx.doi.org/10.3390/cells8121602
_version_ 1783486534838648832
author Li, Xiaobo
Li, Yong
Lu, Weijin
Chen, Minfeng
Ye, Wencai
Zhang, Dongmei
author_facet Li, Xiaobo
Li, Yong
Lu, Weijin
Chen, Minfeng
Ye, Wencai
Zhang, Dongmei
author_sort Li, Xiaobo
collection PubMed
description Tumor vessels provide essential paths for tumor cells to escape from the primary tumor and form metastatic foci in distant organs. The vessel targeting strategy has been widely used as an important clinical cancer chemotherapeutic strategy for patients with metastatic tumors. Our review introduces the contribution of angiogenesis to tumor metastasis and summarizes the application of Food and Drug Administration (FDA)-approved vessel targeting drugs for metastatic tumors. We recommend the application and mechanisms of vascular targeting drugs for inhibiting tumor metastasis and discuss the risk and corresponding countermeasures after vessel targeting treatment.
format Online
Article
Text
id pubmed-6952935
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69529352020-01-23 The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis Li, Xiaobo Li, Yong Lu, Weijin Chen, Minfeng Ye, Wencai Zhang, Dongmei Cells Review Tumor vessels provide essential paths for tumor cells to escape from the primary tumor and form metastatic foci in distant organs. The vessel targeting strategy has been widely used as an important clinical cancer chemotherapeutic strategy for patients with metastatic tumors. Our review introduces the contribution of angiogenesis to tumor metastasis and summarizes the application of Food and Drug Administration (FDA)-approved vessel targeting drugs for metastatic tumors. We recommend the application and mechanisms of vascular targeting drugs for inhibiting tumor metastasis and discuss the risk and corresponding countermeasures after vessel targeting treatment. MDPI 2019-12-10 /pmc/articles/PMC6952935/ /pubmed/31835465 http://dx.doi.org/10.3390/cells8121602 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Li, Xiaobo
Li, Yong
Lu, Weijin
Chen, Minfeng
Ye, Wencai
Zhang, Dongmei
The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
title The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
title_full The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
title_fullStr The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
title_full_unstemmed The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
title_short The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
title_sort tumor vessel targeting strategy: a double-edged sword in tumor metastasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952935/
https://www.ncbi.nlm.nih.gov/pubmed/31835465
http://dx.doi.org/10.3390/cells8121602
work_keys_str_mv AT lixiaobo thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT liyong thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT luweijin thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT chenminfeng thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT yewencai thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT zhangdongmei thetumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT lixiaobo tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT liyong tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT luweijin tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT chenminfeng tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT yewencai tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis
AT zhangdongmei tumorvesseltargetingstrategyadoubleedgedswordintumormetastasis